Hopf, M.; Kloos, C.; Wolf, G.; Müller, U.A.; Müller, N.
Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2. J. Clin. Med. 2021, 10, 571.
https://doi.org/10.3390/jcm10040571
AMA Style
Hopf M, Kloos C, Wolf G, Müller UA, Müller N.
Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2. Journal of Clinical Medicine. 2021; 10(4):571.
https://doi.org/10.3390/jcm10040571
Chicago/Turabian Style
Hopf, Maximilian, Christof Kloos, Gunter Wolf, Ulrich Alfons Müller, and Nicolle Müller.
2021. "Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2" Journal of Clinical Medicine 10, no. 4: 571.
https://doi.org/10.3390/jcm10040571
APA Style
Hopf, M., Kloos, C., Wolf, G., Müller, U. A., & Müller, N.
(2021). Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2. Journal of Clinical Medicine, 10(4), 571.
https://doi.org/10.3390/jcm10040571